Trials / Completed
CompletedNCT04031001
Vascular No-React Graft Against Infection
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 43 (actual)
- Sponsor
- Catharina Ziekenhuis Eindhoven · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This study seeks to demonstrate the effectiveness and safety of the Non-valved Conduit for CE marking on the basis of infection. The rationale for infection resistance with the conduit is that BioIntegral Surgical No-React® treated products have a well-documented history of infection resistance in hybrid vascular settings.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | No-React Non-valved Conduit | Operative replacement of infected graft or implantation in infected area. |
Timeline
- Start date
- 2017-12-22
- Primary completion
- 2021-02-06
- Completion
- 2021-07-13
- First posted
- 2019-07-24
- Last updated
- 2023-12-21
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT04031001. Inclusion in this directory is not an endorsement.